Vivos Inc (QB) (RDGL) News

It is spreading. Word of mouth is a powerful tool. And it's free...




RDGL

Looks like the word is spreading about the success of
ISOPET AND RDGL

That's awesome..

Isopet and team back on tour for another cross country trip to spread the Isopet gospel.


https://x.com/IsoPetForCancer/status/1877782982125347054?t=wZS92V6GiC7zbeYqijmdFA&s=19


RDGL

I would much rather Vivos announce the resubmission of the IDE application augmented with the preliminary results from the initial phase of the overseas human trials. It would be a conflagration if they highlighted positive results in the same PR then gave more detail about the preliminary results in a monthly or quarterly. Support from Benzinga and TradersQue would likely increase the impact of the news.

In October 2024 we got the September 2024 monthly and the 2024 Q3 Report. However, Vivos releasing only a quarterly report could very well be the case.

I'm thinking the same it may be more towards last week but who knows anything could happen.

RDGL is definitely moving upwards...soon enough imo

Maybe taking a little longer since it's probably going to be a quarterly update

Good news on Mondays, bad on Fridays. Preliminary good news we spread like a wild fire.




RDGL

Was thinking we would get the monthly update today, but maybe it will be Monday.

I'm expecting to hear an update on the India human trials in this quarterly update. I'm also expecting those preliminary results to be good if not great. These prices won't last very long. Remember, we may have those year end tax harvesting sellers re-entering their position soon. Perfect storm brewing?

I wasn't aware of his status with the higher ups.  I'm buying more.  We have a real president about to take over who cares about people's lives.  Therefore, the fda is about to go through a massive overhaul 

The longer Doc waits to release monthly/yearly update the more profound the preliminary data will show and be shared.



RDGL

Vivos will likely release significant news this month, based on historical trends. In the past, when Vivos did not release a monthly report before the end of the first seven days of a month Vivos published news that had a positive impact on share price during that month.

He is remarkable. And it's why he was hand picked to be CEO of Vivos inc. You simply can't find another penny stock CEO with his impeccable credentials. There is no other.




RDGL

Wow, very remarkable!

What penny stock CEO has accomplished this?

Great honors Dr. Korenko

https://x.com/VivosIncUSA/status/1877743442396074050?t=XT8Dvstx6QGETCUFGK836Q&s=19



RDGL

Yeah, I figured as much. Thank you.

GOOD LUCK to ya it seems to be a good basket to me

Very good post Chereb.  In short,  Korenko chose lymph nodes for the intial India trials as Lymphoma is a very common cancer, making recruitment of patients much easier, as well as there are numerous lymph nodes throughout the body, allowing for multiple injection sites within a single patient. The purpose of the intial trial is not to specifically cure and remove the cancer, as some misguided persons suggest to mislead others here.  The purpose of the trial is to show the effacy of the radiogel treating the cancer within the lymph node and maintaining the desired safety margins.   This was a brilliant decision by Korenko.  My step-father passed away from lymphatic cancer.  The doctor had removed the identified cancerous nodes, but within six months, an undetected seed had migrated to his brain in an inoperable area and he died quickly after.  Could radiogel have saved him?  Possibly but we will never know.  But thank God now others are finally close to getting the opportunity.  FDA should have approved this months ago but they have been foot dragging and stonewalling.   Intentionally?  I don't know buty own feeling is the current admin and FDA is corrupt has had their own agenda dictated by big pharma, lobbyist and insurance companies. Hopefully the new administration and change of the head of FDA makes a difference to allow innovative treatment to move forward.   Thank goodness Korenko had the foresight to get the India trials started months ago.  We should have the intial safety data report on the 5 patients soon and I've no doubt it will be very good.  That data will supplement the IDE submission as FDA then won't have much reason to delay approval. It's going to be an epic and great year for Vivos and shareholders.  Go $RDGL !!

All good! I have a one big Dinosaur egg in one big basket. 🫣🧐😳




RDGL

Didn't indicate it was a competition, was just making a comment.
I have doubled and possibly tripled my position in the last 3-4 months here

I feel I am just about as loaded with this as I will be, not that I don't believe but , just the fact of I don't put all my eggs in one basket anymore after a BANK I bought into in April of 2008

It's not a competition. We buy what we can afford to lose. Or like me, instead of buying that $20k boat and $11k jetski, I'll buy RDGL instead. It's a gamble, but a gamble that just might pay off and I'll be able to buy that boat and jet ski with cash. We'll see.

Life's a gamble, just don't bet your house on it.



RDGL

One step at a time

Not as many as many here holding

Starting a Phase 1 trial for RadioGel® Precision Radionuclide Therapy™ in patients with cancerous lymph nodes is a strategically smart decision for several reasons. Lymph nodes are critical sites in cancer progression, often acting as gateways for metastatic spread. By targeting cancerous nodes, the trial focuses on an area of high clinical relevance where effective localized treatment could have meaningful therapeutic and palliative impacts. Additionally, lymph nodes are relatively accessible for imaging and treatment delivery, simplifying the process of demonstrating precision placement and monitoring outcomes—key goals in a Phase 1 trial. This approach allows Vivos to highlight the safety and precision of RadioGel® in a real-world scenario while addressing an urgent medical need in advanced cancers.

Moreover, there is a compelling hypothesis that treating cancerous lymph nodes could indirectly benefit the primary tumor. Research suggests that lymph nodes play a crucial role in immune system interactions and tumor microenvironment dynamics. By effectively treating metastatic nodes, the therapy might reduce the spread of cancer cells and potentially weaken the tumor’s systemic support. This opens the door for synergistic effects when used alongside other treatments, such as chemotherapy or immunotherapy. Demonstrating such outcomes in this trial could position RadioGel® as a highly versatile tool in oncology, paving the way for broader applications in treating both primary and secondary cancers.

Do you believe the preliminary safety and effectiveness data collected from the initial 5 patients will be sufficient for the pending IDE submission or will Vivos need to provide more comprehensive results from the larger pool of 30 patients?

I honestly cant wait for the coming admin to begin "cleaning house" at the FDA / CDC / NIH of all these corrupt officials.

The liar keeps CON-veniently ignoring the part where its stated that the patients selected have very limited to no other options for treatment and that its preliminary safety and effectiveness data being sought as opposed to final outcomes.

Basically, due to method of administration and the mechanics of Radiogel , its likely their best option for a partial or full recovery.

What does that have to do with anything? Radiogel treats a single tumor/locality no matter to what degree the cancer has spread throughout the rest of the patient's body. The object of the exercise and efficacy would be demonstrated by 1. The treated tumor succumbs 2. The radiogel staying put instead of migrating through the patients system.

Can’t wait for the December report should be any day now!

This trial represents not just a milestone for Vivos, but a pivotal moment for the entire field of oncology. We eagerly anticipate sharing preliminary results soon and comprehensive findings upon trial completion

Remember this SC8: there is a reason for the above statement IMO. The guess is you'll find out soon enough. For now, keep talking.

You're too blind to even see the contradictions is your rants. If radiogel is good at treating early detected tumors (as proven by animal trial) and is now being tested for treating cancers in lymph nodes which essentially means an expanded application of radiogel. Is that a good thing or bad thing? Also, what do you suppose was the underlying reasons for the decisions of the trial investigator(s) to expand the pool of patients?

The lymph nodes are the primary tumors. But nice try at twisting another lie.




RDGL

RDGL

Again, you're making my point. There was nothing stopping Radiogel human trials a decade ago beyond MK's own incompetence.

Can't demonstrate Radiogel efficacy if the cancer kills the patient. What was the point?

That's MK for ya. Claims successfully treated when there's no way the impact of Radiogel on these patients and their cancers could be known this soon. Hence why everything he submits to FDA gets put under a magnifying glass. They know how incompetent he is with his repeated bogus product attribute and comparative safety claims.

Link?



RDGL

Nope that's our ever so slow knuckle dragging FDA. Answer this, why is it taking over 10 years for FDA to give MK IDE approve when it took India just a couple months? MK has made so much significant progress that their ready to treat another 30 patients with Radiogel, or maybe they already did. Soon we'll find out.

So who's the incompetent crew holding up a life saving device? FDA/BP don't give 2 shit about curing cancer, they only care if you're on their product.


RDGL

Your point? Trials are to demonstrate efficacy.... this is a treatment not a cure... 

From MK's own pen. The 5 patients had cancers in neck lymph nodes treated with Radiogel. So the cancers had already spread from primary tumor to the lymph nodes and likely beyond. There are no bounds to MK's incompetence.

It clearly states successful treatment and patients are recovering well with no complications... expanding trial to 30 patients. You are clearly bashing this stock and outright lying about information the company has pr'd 

Where are you reading any of this? Cut the spewing of bs...

We've been told for years Radiogel is for early detected solid tumors that hadn't spread. Now the first human trial is treating cancers that have already spread to lymph nodes. The incompetence is beyond belief.

Again, no way to evaluate effectiveness, as these patient's cancers have already spread. Leave it to MK to try and pound the square peg into the round hole. He's just hell bent on destroying RDGL.

Why is the spread to other lymph nodes Mk fault? And link please to this info.



RDGL

8 or 10 years, point is MK has lead RDGL close to a decade and is only starting human trials now. That's gross incompetence.

And so? What happened to Radiogel curing early detected cancers that hadn't spread yet? What good is Radiogel going to do with cancer that has already spread? The continued incompetence is beyond belief.

The present is MK is a proven serial liar and gross incompetent. The present is the now over a year old BDD "news" proved irrelevent. The present is RDGL has treated 5 patients who's cancers had already spread to lymph lodes, further demonstrating MK's gross incompetence. It is what it is. That is the present.

from chemist72: "That is why the PR states plainly:
Upon anticipated completion of this trial in the first half of 2025

Going by your interpretation of the statement, I don't see where the contradiction lies. Assuming your interpretation align with Vivos, then the merrier here for investors IMO since the completion of trial and final report could occur anytime from now and first half of 2025.

What no one can misinterprete from the statement, however, is the fact that Vivos anticipates the announcement of preliminary report prior to the announcement of trial final report and publication in medical journal. One precedes the other.

The "truth" is that RDGL is doing human trials in India.

At least that is what the boss says and I believe him.

But read carefully what else he says in that PR. At Vivos, our policy is to communicate results—not just promises. Ok. What else does he say? We eagerly anticipate sharing preliminary results soon and comprehensive findings upon trial completion Well how about that? So posters on iHub can say the trials could end this month or even next month. But the "truth" is nobody knows for sure. Even Dr. K probably doesn't know for sure. That is why the PR states plainly: Upon anticipated completion of this trial in the first half of 2025 That means that trials could be completed anytime between Jan. 1, 2025 and May 31, 2025. Plain and simple.